Literature DB >> 9106034

Gas chromatographic-mass spectrometric analysis of the loop diuretic torasemide in human urine.

M B Barroso1, H D Meiring, A de Jong, R M Alonso, R M Jiménez.   

Abstract

A fast and reliable gas chromatographic-mass spectrometric (GC-MS) method for the identification and determination of the loop diuretic torasemide in human urine is described. The usefulness of different derivatization procedures and reagents was studied. Flash methylation using trimethylanilinium hydroxide was the most convenient and appropriate procedure. The optimal urine isolation method comprised alkaline liquid-liquid extraction with ethyl acetate. After evaporation of the organic layer to dryness, the solid residue was reconstituted in the derivatizing reagent and was directly injected into the GC-MS system. Samples were analysed in the multiple ion detection mode using electron impact ionization. No interferences from other urinary compounds were found. Torasemide gave rise to a derivative that was identified by GC with Fourier transform infrared detection. There was a 70 +/- 5% recovery of torasemide. The coefficient of variation was 5% at a concentration of 0.05 microgram/ml. The method was used for the determination of torasemide in urine samples obtained from a healthy volunteer that had received a single, 10 mg dose of torasemide.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9106034     DOI: 10.1016/s0378-4347(96)00392-1

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  2 in total

1.  Determination of torasemide in human plasma and its bioequivalence study by high-performance liquid chromatography with electrospray ionization tandem mass spectrometry.

Authors:  Lin Zhang; Rulin Wang; Yuan Tian; Zunjian Zhang
Journal:  J Pharm Anal       Date:  2015-11-11

2.  A simplified HPLC method for quantification of torsemide from human plasma and its application to a bioequivalence study.

Authors:  I J Khan; P Loya; M N Saraf
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.